NUPLAZID
NDC 63090-100, pimavanserin tartrate, tablet, coated, from Acadia Pharmaceuticals Inc..
- Product NDC
- 63090-100
- Status
- Listed
- Labeler
- Acadia Pharmaceuticals Inc.
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA207318
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63090-100 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PIMAVANSERIN TARTRATE10 mg/1
Pharmacologic classes
Atypical Antipsychotic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63090-100-30 | 63090010030 | 30 TABLET, COATED in 1 BOTTLE, PLASTIC (63090-100-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1e6bea44-57d6-4bac-9328-46e1ee59f83b
Use it
Look up 63090-100 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63090-100 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63090-100. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.